減損損失 - 医薬品、繰延税金負債、原材料他1件
- 【期間】
| 年度 | 減損損失 - 医薬品 | 繰延税金負債 | 原材料 | 有形固定資産（IFRS） |
|---|
| 2008/03 | - | | - | | - | | - | |
| 2009/03 | - | | - | | - | | - | |
| 2010/03 | - | | - | | - | | - | |
| 2011/03 | - | | - | | - | | - | |
| 2012/03 | - | | - | | - | | - | |
| 2013/03 | 4.3億 | | - | | - | | - | |
| 2014/03 | 70.9億 | 大幅増 | - | | - | | - | |
| 2015/03 | 53.1億 | -25.1% | - | | - | | - | |
| 2016/03 | 5.53億 | -89.6% | - | | - | | - | |
| 2017/03 | - | | - | | - | | - | |
| 2018/03 | - | | - | | 1241億 | | 6757億 | |
| 2019/03 | - | | 215億 | | 1365億 | +10% | 7359億 | +8.9% |
| 2020/03 | - | | 166億 | -22.7% | 1284億 | -5.9% | 7784億 | +5.8% |
| 2021/03 | - | | 284億 | +70.9% | 1402億 | +9.2% | 7935億 | +1.9% |
| 2022/03 | - | | 191億 | -32.6% | 2106億 | +50.2% | 8230億 | +3.7% |
| 2023/03 | - | | 192億 | +0.4% | - | | 8294億 | +0.8% |
| 2024/03 | - | | - | | - | | 7965億 | -4% |
